Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for STERIS plc (STE : NYSE)
 
 • Company Description   
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

Number of Employees: 13,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $221.63 Daily Weekly Monthly
20 Day Moving Average: 486,454 shares
Shares Outstanding: 100.13 (millions)
Market Capitalization: $22,191.19 (millions)
Beta: 0.67
52 Week High: $255.93
52 Week Low: $188.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.40% -2.22%
12 Week -3.37% 1.73%
Year To Date -8.95% 6.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
70 Sir John Rogerson`s Quay
-
Dublin,L2 D02 R296
IRL
ph: 353-1232-2000
fax: 440-639-4457
julie_winter@steris.com http://www.steris.com
 
 • General Corporate Information   
Officers
Walter M Rosebrough - Chief Executive Officer;President
Mohsen M. Sohi - Chairman and Director
Michael J. Tokich - Senior Vice President and Chief Financial Officer
Karen L. Burton - Vice President; Controller and Chief Accounting Of
Richard C. Breeden - Director

Peer Information
STERIS plc (ABMD)
STERIS plc (DMDS)
STERIS plc (CPWY.)
STERIS plc (EQUR)
STERIS plc (ECIA)
STERIS plc (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: G8473T100
SIC: 3842
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 100.13
Most Recent Split Date: 8.00 (2.00:1)
Beta: 0.67
Market Capitalization: $22,191.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.78%
Current Fiscal Quarter EPS Consensus Estimate: $1.86 Indicated Annual Dividend: $1.72
Current Fiscal Year EPS Consensus Estimate: $8.71 Payout Ratio: 0.22
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: -0.05
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/24/2022 - $0.43
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 25.44
Trailing 12 Months: 28.02
PEG Ratio: -
Price Ratios
Price/Book: 3.39
Price/Cash Flow: 32.40
Price / Sales: 4.84
EPS Growth
vs. Year Ago Period: 25.15%
vs. Previous Quarter: -3.77%
Sales Growth
vs. Year Ago Period: 38.60%
vs. Previous Quarter: 0.14%
ROE
03/31/22 - 11.85
12/31/21 - 12.08
09/30/21 - 12.44
ROA
03/31/22 - 6.63
12/31/21 - 6.78
09/30/21 - 7.02
Current Ratio
03/31/22 - 2.04
12/31/21 - 2.13
09/30/21 - 2.42
Quick Ratio
03/31/22 - 1.41
12/31/21 - 1.47
09/30/21 - 1.71
Operating Margin
03/31/22 - 16.99
12/31/21 - 16.81
09/30/21 - 16.89
Net Margin
03/31/22 - 5.32
12/31/21 - 6.57
09/30/21 - 6.50
Pre-Tax Margin
03/31/22 - 6.86
12/31/21 - 8.92
09/30/21 - 8.73
Book Value
03/31/22 - 65.36
12/31/21 - 66.22
09/30/21 - 65.61
Inventory Turnover
03/31/22 - 4.42
12/31/21 - 4.69
09/30/21 - 5.02
Debt-to-Equity
03/31/22 - 0.45
12/31/21 - 0.48
09/30/21 - 0.52
Debt-to-Capital
03/31/22 - 31.04
12/31/21 - 32.40
09/30/21 - 34.33
 

Powered by Zacks Investment Research ©